Header cover image

U.S. Pharmaceuticals & Biotech Construction Boom

UPDATED May 04, 2024

Highly cyclical companies in construction-related industries with a strong future outlook.

58 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

TGTX

TG Therapeutics		US$16.1920.2%-52.8%US$2.3bUS$31.50PE56.9xE46.2%n/a

HALO

Halozyme Therapeutics		US$39.913.5%28.7%US$5.1bUS$50.70PE18xE20.7%n/a

DVAX

Dynavax Technologies		US$11.744.7%4.2%US$1.5bUS$24.67PS6.6xE43.6%n/a

AMRN

Amarin		US$0.914.0%-34.5%US$373.9mUS$1.00PS1.3xE54.9%n/a

RCEL

AVITA Medical		US$8.752.7%-46.5%US$225.7mUS$25.90PS4.5xE62.0%n/a

ZVRA

Zevra Therapeutics		US$4.816.4%-2.0%US$201.3mUS$19.00PS7.3xE63.6%n/a

ARCT

Arcturus Therapeutics Holdings		US$27.272.7%0.6%US$734.3mUS$67.89PS4.4xE60.0%n/a

EXAS

Exact Sciences		US$62.075.5%-7.8%US$11.4bUS$89.48PS4.6xE61.9%n/a

SPPI

Spectrum Pharmaceuticals		US$1.035.3%17.0%US$209.9mUS$1.26PS8.2xE67.3%n/a

CDXC

ChromaDex		US$3.789.9%177.9%US$285.4mUS$6.08PS3.4xE93.2%n/a

MIRM

Mirum Pharmaceuticals		US$25.845.6%-1.5%US$1.2bUS$48.91PS6.5xE65.6%n/a

AUPH

Aurinia Pharmaceuticals		US$5.103.9%-55.9%US$729.4mUS$10.14PS3.8xE52.0%n/a

LAB

Standard BioTools		US$2.512.9%54.9%US$960.0mUS$3.58PS9xE46.7%n/a

CTXR

Citius Pharmaceuticals		US$0.706.0%-44.9%US$127.3mUS$4.00PB1.5xE62.7%n/a

VCEL

Vericel		US$47.833.9%44.8%US$2.3bUS$53.90PS11.7xE49.3%n/a

ZYNE

Zynerba Pharmaceuticals		US$1.304.0%96.1%US$65.6mUS$1.26PB2.3xE67.2%n/a

MEDP

Medpace Holdings		US$392.57-0.8%89.8%US$12.1bUS$423.17PE38.9xE13.8%n/a

CAPR

Capricor Therapeutics		US$5.471.1%39.5%US$172.3mUS$21.00PS6.8xE59.4%n/a

GTHX

G1 Therapeutics		US$4.4912.5%45.8%US$234.7mUS$8.50PS2.8xE41.0%n/a

TLRY

Tilray Brands		US$2.1018.0%-24.2%US$1.7bUS$2.37PS2.3xE86.1%n/a

HBIO

Harvard Bioscience		US$3.856.4%-37.5%US$167.2mUS$7.00PS1.5xE98.9%n/a

PTGX

Protagonist Therapeutics		US$26.093.7%5.2%US$1.5bUS$43.00PS25.5xE50.0%n/a

SNDL

SNDL		US$2.3516.9%35.8%US$618.2mUS$3.61PB0.7xE135.8%n/a

PGEN

Precigen		US$1.420.7%16.4%US$358.4mUS$9.00PS57.6xE55.5%n/a
Page 1 of 3
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.